Literature DB >> 15499529

Interleukin (IL)-12 and IL-23 are key cytokines for immunity against Salmonella in humans.

Calman MacLennan1, Claire Fieschi, David A Lammas, Capucine Picard, Susan E Dorman, Ozden Sanal, Jenny M MacLennan, Steven M Holland, Tom H M Ottenhoff, Jean-Laurent Casanova, Dinakantha S Kumararatne.   

Abstract

Patients with inherited deficiency of the interleukin (IL)-12/IL-23-interferon (IFN)- gamma axis show increased susceptibility to invasive disease caused by the intramacrophage pathogens salmonellae and mycobacteria. We analyzed data on 154 patients with such deficiency. Significantly more patients with IL-12/IL-23-component deficiency had a history of salmonella disease than did those with IFN- gamma -component deficiency. Salmonella disease was typically severe, extraintestinal, and caused by nontyphoidal serovars. These findings strongly suggest that IL-12/IL-23 is a key cytokine for immunity against salmonella in humans and that IL-12/IL-23 mediates this protective effect partly through IFN- gamma -independent pathways. Investigation of the IL-12/IL-23-IFN- gamma axis should be considered in patients with invasive salmonella disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15499529     DOI: 10.1086/425021

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  74 in total

Review 1.  Capsule-mediated immune evasion: a new hypothesis explaining aspects of typhoid fever pathogenesis.

Authors:  Manuela Raffatellu; Daniela Chessa; R Paul Wilson; Cagla Tükel; Mustafa Akçelik; Andreas J Bäumler
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

2.  Characterization of an IL-12 p40/p35 Truncated Fusion Protein That can Inhibit the Action of IL-12.

Authors:  Denise Skrombolas; Isabel Wylie; Shivana Maharaj; John G Frelinger
Journal:  J Interferon Cytokine Res       Date:  2015-05-04       Impact factor: 2.607

3.  Current Status of the Management of Mendelian Susceptibility to Mycobacterial Disease in Mainland China.

Authors:  Wenjing Ying; Danru Liu; Xiaolong Dong; Wenjie Wang; Xiaoying Hui; Jia Hou; Haili Yao; Qinhua Zhou; Bijun Sun; Jinqiao Sun; Xiaochuan Wang
Journal:  J Clin Immunol       Date:  2019-07-31       Impact factor: 8.317

4.  Presentation of interleukin-12/-23 receptor beta1 deficiency with various clinical symptoms of Salmonella infections.

Authors:  Ozden Sanal; Tuba Turul; Tijtske De Boer; Esther Van de Vosse; Işik Yalcin; Ilhan Tezcan; Cağman Sun; L Memis; Tom H M Ottenhoff; Fugen Ersoy
Journal:  J Clin Immunol       Date:  2006-01       Impact factor: 8.317

Review 5.  Chemical mutagenesis: a new strategy against the global threat of infectious diseases.

Authors:  Etienne Richer; Salman T Qureshi; Silvia M Vidal; Danielle Malo
Journal:  Mamm Genome       Date:  2008-06-17       Impact factor: 2.957

6.  A 1,100-year-old founder effect mutation in IL12B gene is responsible for Mendelian susceptibility to mycobacterial disease in Tunisian patients.

Authors:  Imen Ben-Mustapha; Meriem Ben-Ali; Najla Mekki; Etienne Patin; Christine Harmant; Jihène Bouguila; Houda Elloumi-Zghal; Abdelaziz Harbi; Mohamed Béjaoui; Lamia Boughammoura; Jalel Chemli; Mohamed-Ridha Barbouche
Journal:  Immunogenetics       Date:  2013-10-15       Impact factor: 2.846

Review 7.  IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases.

Authors:  Michele W L Teng; Edward P Bowman; Joshua J McElwee; Mark J Smyth; Jean-Laurent Casanova; Andrea M Cooper; Daniel J Cua
Journal:  Nat Med       Date:  2015-06-29       Impact factor: 53.440

8.  Targeting IL-23: insights into the pathogenesis and the treatment of psoriasis.

Authors:  Hermenio Cavalcante Lima; Alexandra Boer Kimball
Journal:  Indian J Dermatol       Date:  2010 Apr-Jun       Impact factor: 1.494

9.  Review of ustekinumab, an interleukin-12 and interleukin-23 inhibitor used for the treatment of plaque psoriasis.

Authors:  Nora Koutruba; Jason Emer; Mark Lebwohl
Journal:  Ther Clin Risk Manag       Date:  2010-04-15       Impact factor: 2.423

10.  Early interferon-γ production in human lymphocyte subsets in response to nontyphoidal Salmonella demonstrates inherent capacity in innate cells.

Authors:  Tonney S Nyirenda; Anna E Seeley; Wilson L Mandala; Mark T Drayson; Calman A MacLennan
Journal:  PLoS One       Date:  2010-10-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.